NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE113309 Query DataSets for GSE113309
Status Public on Apr 19, 2018
Title BMI1 drives metastasis of prostate cancer in Caucasian and African-American men and is a potential therapeutic target: hypothesis tested in race-specific models
Organism Homo sapiens
Experiment type Expression profiling by RT-PCR
Summary MDA-PCa2b cells were treated with PCT-209 or control (DMSO) for 24h and subjected to the qRT-PCR based microarray analysis (Qiagen, Germantown, MD).
 
Overall design qPCR gene expression profiling. Metaststic African american prostate cancer cell line MDA-Pca2b cells were treated with BMI-1 inhibitor PTC-209 or control as indicated in the summary. Equal amount total RNA from Treated and control was used for gene expression analysis.
 
Contributor(s) Saleem M, Beigh FH
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 18, 2018
Last update date Apr 20, 2018
Contact name Mohammad Saleem
Organization name University of Minnesota
Department Urology
Lab Molecular Therapeutics and Cancer Health Disparity
Street address 2231 6th St SE
City Minneapolis
State/province Mn
ZIP/Postal code 55455
Country USA
 
Platforms (1)
GPL24904 RT² Profiler PCR Array Human Prostate Cancer
Samples (2)
GSM3103119 Control-MDA-PCa2b
GSM3103120 PTC-209 treated MDA-Pca2b
Relations
BioProject PRJNA450790

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE113309_Microarray_List-MDA-PCa2b_expt-final.xls.gz 20.6 Kb (ftp)(http) XLS
GSE113309_data_worksheets.xlsx 26.6 Kb (ftp)(http) XLSX
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap
External link. Please review our privacy policy.